Insider Trading & Ownership of GENMAB A/S

Location
1253 Copenhagen K, Denmark
Signature
/s/ Jan G. J. van de Winkel, President and Chief Executive Officer, Genmab A/S
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow GENMAB A/S and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • GENMAB A/S has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value is not available.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Merus N.V. ($0).
  • Past-year value change for that position: -$7,124,260,351.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of GENMAB A/S

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MRUS Merus N.V. 10%+ Owner $0 -$7,124,260,351 -100% 26 Dec 2025

Insider Transactions Reported by GENMAB A/S:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored